Mitchell W Krucoff

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Lancet 366:211-7. 2005
  2. ncbi request reprint Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion
    Mitchell W Krucoff
    eECG Core Laboratory, Duke University Medical Center Duke Clinical Research Institute, Durham, North Carolina, USA
    Circulation 110:e533-9. 2004
  3. doi request reprint Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
    Mohamed Majidi
    eECG Core Laboratory, Duke Clinical Research Institute, 508 Fulton Street, Durham, NC 27705, USA
    Eur Heart J 30:757-64. 2009
  4. ncbi request reprint Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)
    Abdallah G Rebeiz
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 95:611-4. 2005
  5. doi request reprint Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank
    Sana M Al-Khatib
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 160:619-26. 2010
  6. doi request reprint A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 51:1543-52. 2008
  7. doi request reprint A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 4:1298-309. 2011
  8. doi request reprint Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and D
    L Kristin Newby
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715 7969, USA
    Am Heart J 162:64-73. 2011
  9. ncbi request reprint Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction
    Matthew T Roe
    Duke Clinical Research Institute and Division of Cardiology, Duke Medical Center, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 43:549-56. 2004
  10. doi request reprint Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database
    John L Petersen
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 159:462-470.e1. 2010

Detail Information

Publications58

  1. ncbi request reprint Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Durham, NC 27705, USA
    Lancet 366:211-7. 2005
    ..We undertook a multicentre, prospective trial of two such practices: intercessory prayer and music, imagery, and touch (MIT) therapy...
  2. ncbi request reprint Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion
    Mitchell W Krucoff
    eECG Core Laboratory, Duke University Medical Center Duke Clinical Research Institute, Durham, North Carolina, USA
    Circulation 110:e533-9. 2004
  3. doi request reprint Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
    Mohamed Majidi
    eECG Core Laboratory, Duke Clinical Research Institute, 508 Fulton Street, Durham, NC 27705, USA
    Eur Heart J 30:757-64. 2009
    ..Well-characterized reperfusion VAs may provide a novel biomarker of reperfusion injury...
  4. ncbi request reprint Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)
    Abdallah G Rebeiz
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 95:611-4. 2005
    ..7% vs 48.0% with >/=50% ST-segment resolution, p = 0.03) and sustained over 180 minutes after drug administration; this transient benefit may suggest a time frame when more optimal percutaneous coronary intervention can be performed...
  5. doi request reprint Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank
    Sana M Al-Khatib
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 160:619-26. 2010
    ....
  6. doi request reprint A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 51:1543-52. 2008
    ....
  7. doi request reprint A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    JACC Cardiovasc Interv 4:1298-309. 2011
    ....
  8. doi request reprint Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and D
    L Kristin Newby
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715 7969, USA
    Am Heart J 162:64-73. 2011
    ..This article summarizes collaborative discussions among key stakeholders in the Cardiac Safety Research Consortium about the use of cTn monitoring in drug development...
  9. ncbi request reprint Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction
    Matthew T Roe
    Duke Clinical Research Institute and Division of Cardiology, Duke Medical Center, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 43:549-56. 2004
    ....
  10. doi request reprint Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database
    John L Petersen
    Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
    Am Heart J 159:462-470.e1. 2010
    ..Relationships between long-term use and level of dual antiplatelet therapy and outcomes after drug-eluting stent implantation are not well established...
  11. ncbi request reprint ST-segment monitoring in patients with acute coronary syndromes
    Per Johanson
    Duke University Medical Center, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27705, USA
    Curr Cardiol Rep 5:278-83. 2003
    ..Continuous multilead ST-monitoring during ACS is no longer a cumbersome source of more nuisance than benefit, but can be an accurate and useful tool in multicenter clinical trials, as well as in clinical medicine...
  12. ncbi request reprint Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction
    Arthur C P Maas
    Duke University Medical Center, Durham, NC, USA
    Am Heart J 147:698-704. 2004
    ....
  13. doi request reprint Postmarket evaluation of breakthrough technologies
    Sunil V Rao
    Duke Clinical Research Institute and Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 156:201-8. 2008
    ....
  14. doi request reprint Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative
    Jonathan P Piccini
    Duke Clinical Research Institute and Duke University Medical Center, Durham, NC 27705, USA
    Am Heart J 158:317-26. 2009
    ..Priority pursuit of these consensus-based directions should facilitate both safer drugs and accelerated access to new drugs, as concomitant public health benefits...
  15. ncbi request reprint The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents
    Tracy Y Wang
    Duke Clinical Research Institute, Duke University, Durham, NC, USA
    Am Heart J 153:743-8. 2007
    ..The results of COSTAR II will provide information about a novel coronary stent device as well as unique data regarding both control and test DES use in more complex "real-world" patients...
  16. ncbi request reprint Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
    Mitchell W Krucoff
    Duke University Medical Center Duke Clinical Research Institute, Durham, NC 27705, USA
    Circulation 115:2990-4. 2007
  17. ncbi request reprint Simultaneous restenosis of Taxus and Cypher drug-eluting stents
    Kent R Nilsson
    Department of Medicine, Division of Cardiology, Box 31097, Duke University Medical Center, Durham, NC, USA
    J Invasive Cardiol 18:557-60. 2006
  18. doi request reprint From ST-elevation myocardial infarction to ST elevation with no myocardial infarction--review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices
    Mitchell W Krucoff
    Duke University Medical Center, Duke Clinical Research Institute, 508 Fulton Street 111A, Durham, NC 27705, USA
    J Electrocardiol 42:487-93. 2009
    ..Rapidly progressive changes in the endocardial electrogram, with real-time alarms, could shift the timing, and hence the paradigm of care from interruption of MI to prevention of MI...
  19. doi request reprint Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective
    Mitchell W Krucoff
    Duke University Medical Center Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27705, USA
    JACC Cardiovasc Interv 5:790-6. 2012
    ..Professional societies are well positioned to convene pre-competitive dialogue, facilitate alignment, and add perspective to equipoise within the innovation ecosystem...
  20. doi request reprint TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium
    Connie N Hess
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
    Am Heart J 165:344-53.e1. 2013
    ..This article summarizes the content and proceedings of these sessions...
  21. ncbi request reprint The first ISCE Board of "Trustees" overview panel session: ischemia monitoring, state of the art. International Society of Computerized Electrocardiology
    Katherine J Booker
    Duke University Medical Center, Durham, NC 27705, USA
    J Electrocardiol 35:207-30. 2002
  22. ncbi request reprint Correlations between preprocedure mood and clinical outcome in patients undergoing coronary angioplasty
    Gregory E Grunberg
    Division of Cardiology, Department of Medicine, Durham Veterans Administration Medical Center and the Duke Clinical Research Institute, Durham, North Carolina, USA
    Cardiol Rev 11:309-17. 2003
    ..Our data suggest correlations between simple mood assessments before PCI and clinical outcomes during and after the procedure. More study is needed to understand whether attempts to alter patient mood can affect clinical outcomes...
  23. ncbi request reprint Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries
    R David Anderson
    Duke Clinical Research Institute, Durham, NC, USA
    Am Heart J 144:81-8. 2002
    ..Whether prognostically useful information can be achieved as early as 90 minutes after thrombolysis is unknown...
  24. doi request reprint Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias
    Mohamed Majidi
    Duke Clinical Research Institute, 508 Fulton Street, Room A3012, Durham, NC 27705, USA
    Europace 10:988-97. 2008
    ....
  25. ncbi request reprint Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study)
    David E Kandzari
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 93:636-9. 2004
    ..5 degrees C) and was well tolerated, which supports the evaluation of adjunctive hypothermia in pivotal trials to limit infarct size and decrease reperfusion injury...
  26. ncbi request reprint Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative
    Christopher H Cabell
    Department of Medicine, Duke University School of Medicine, Durham, NC, USA Duke Clinical Research Institute, Durham, NC 27715, USA
    J Electrocardiol 38:175-9. 2005
    ..The FDA Electrocardiogram Warehouse is 1 example where a government resource could be used by a confluence of groups to improve the science surrounding important components of the drug approval process such as cardiac safety evaluation...
  27. doi request reprint Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank
    Sana M Al-Khatib
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 159:17-24. 2010
    ..The meeting took place on April 27 to 28, 2009, at the US Food and Drug Administration headquarters in Silver Spring, MD. This article summarizes the issues and directions presented and discussed at the meeting...
  28. ncbi request reprint Permanently implantable diagnostic computerized devices: where is the regulatory rar?
    Mitchell W Krucoff
    eECG Core Laboratory, Duke University Medical Center Duke Clinical Research Institute, Durham, NC 27705, USA
    J Electrocardiol 37:68-70. 2004
  29. ncbi request reprint Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function
    Domien J Engelen
    Department of Cardiology, University Hospital Maastricht, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands
    Am J Cardiol 92:1143-9. 2003
    ..This supports the hypothesis that these reperfusion arrhythmias are probably a noninvasive marker of cellular injury...
  30. ncbi request reprint Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression
    Marko N Kostic
    Signalife, Inc, Studio City, CA 91607, USA
    Conf Proc IEEE Eng Med Biol Soc 2007:2199-202. 2007
    ..A qualitative performance of baseline wander suppression was done on all five systems. The results showed that the Fidelity 100 system provided excellent detection and quantification of transient ischemia and baseline wander suppression...
  31. doi request reprint Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery
    Miguel E Lemmert
    Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    Heart Rhythm 5:71-8. 2008
    ..Sudden cardiac death caused by ischemic ventricular fibrillation (VF) associated with ST elevation myocardial infarction (STEMI) is one of the most frequent causes of death...
  32. ncbi request reprint Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial)
    David E Kandzari
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am J Cardiol 92:660-4. 2003
    ..These results support the evaluation of MC-1 in pivotal trials of patients at risk for developing myocardial ischemia, infarction, or reperfusion injury...
  33. doi request reprint Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)
    George Dangas
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 155:1090-6. 2008
    ..The value of distal protection devices during rescue PCI has not been studied...
  34. ncbi request reprint Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the Inte
    Barbara J Drew
    Circulation 110:2721-46. 2004
    ..Currently available ECG lead systems are described, and recommendations related to staffing, training, and methods to improve quality are provided...
  35. ncbi request reprint Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction
    C Michael Gibson
    TIMI Study Group, The Department of Medicine, Brigham and Women s Hospital, Boston, Mass, USA
    Am Heart J 147:847-52. 2004
    ..However, no data exist comparing the speed of ST resolution on continuous electrocardiogram (ECG) monitoring with the TMPG on coronary angiography. We hypothesized that delayed ST res is associated with impaired TMPGs...
  36. ncbi request reprint "Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction
    Birgit Jurlander
    The Heart Center, Copenhagen University Hospital, Rigshospitalet, and Hillerød, Sygehus, Copenhagen, Denmark
    Am Heart J 146:757-63. 2003
    ..This study presents a combined method for clinical use, based on the "mirror-lake" tendency of the serial changes in these markers...
  37. ncbi request reprint Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)
    Steven P Marso
    The Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    Am J Cardiol 100:206-10. 2007
    ....
  38. ncbi request reprint The truth and consequences of the COURAGE trial
    Dean J Kereiakes
    Christ Hospital Heart and Vascular Center the Lindner Research Center, Cincinnati, Ohio 45219, USA
    J Am Coll Cardiol 50:1598-603. 2007
    ..An in-depth analysis of the COURAGE trial design and execution is provided...
  39. ncbi request reprint Surrogates, substudies, and real clinical end points in trials of drug-eluting stents
    Dean J Kereiakes
    J Am Coll Cardiol 45:1206-12. 2005
  40. ncbi request reprint Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia
    Stefan P Nelwan
    Thoraxcentrum, Erasmus MC, Rotterdam, The Netherlands
    Am J Cardiol 94:1529-33. 2004
    ..These approaches appear to be more practical than conventional 10-electrode monitoring but preserve high accuracy...
  41. ncbi request reprint Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model
    Tim A Fischell
    Borgess Heart Institute, Michigan State University, Kalamazoo, Michigan 49048, USA
    J Am Coll Cardiol 48:2306-14. 2006
    ....
  42. ncbi request reprint Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial
    Barbara J Drew
    Department of Physiological Nursing, University of California, San Francisco, CA 94143 0610, USA
    J Electrocardiol 37:214-21. 2004
    ..The present analysis reports results of the feasibility pilot study...
  43. ncbi request reprint Clinical end points in coronary stent trials: a case for standardized definitions
    Donald E Cutlip
    Harvard Clinical Research Institute, Harvard Medical School, 930 Commonwealth Avenue, Boston, MA 02215, USA
    Circulation 115:2344-51. 2007
    ..Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of assessment have created confusion in interpretation...
  44. ncbi request reprint Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion
    Tim A Fischell
    Borgess Heart Institute, Kalamazoo, MI 49048, USA
    Cardiovasc Revasc Med 6:14-20. 2005
    ..Early identification of acute MI and prompt intervention can improve clinical outcomes. It would be valuable to identify a method that could allow the earliest possible detection of myocardial injury or ischemia...
  45. ncbi request reprint Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion
    Stephan P Nelwan
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    J Electrocardiol 37:171-2. 2004
  46. ncbi request reprint Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial
    Gregg W Stone
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA
    JAMA 293:1063-72. 2005
    ....
  47. ncbi request reprint Thrombosis and drug-eluting stents: an objective appraisal
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55955, USA
    J Am Coll Cardiol 50:109-18. 2007
    ....
  48. ncbi request reprint A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy
    Per Johanson
    Division of Cardiology, Sahlgrenska University Hospital Ostra, SE 41685 Goteborg, Sweden
    Eur Heart J 26:1726-33. 2005
    ..We investigated a model for such forecasting, using time and the ECG...
  49. ncbi request reprint AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Y
    Barbara J Drew
    J Cardiovasc Nurs 20:76-106. 2005
    ..Currently available ECG lead systems are described, and recommendations related to staffing, training, and methods to improve quality are provided...
  50. ncbi request reprint From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP)
    Mitchell W Krucoff
    Am Heart J 151:762-4. 2006
  51. ncbi request reprint Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination
    Barbara J Drew
    Department of Physiological Nursing, N631H, University of California, San Francisco, CA 94143 0610, USA
    J Electrocardiol 39:S157-60. 2006
    ....
  52. ncbi request reprint Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study
    Frits W Bär
    Department of Cardiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Eur Heart J 27:2516-23. 2006
    ..To examine the safety and efficacy of intravenous caldaret in patients with large acute ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI)...
  53. ncbi request reprint Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire?
    William C Wijns
    Eur Heart J 27:2737-9. 2006
  54. doi request reprint Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion
    Stefan P Nelwan
    Thoraxcentrum, Erasmus MC, Rotterdam, The Netherlands
    J Electrocardiol 41:230-7. 2008
    ..The aim of the study was to simultaneously test the EASI lead system and two other derived ECG methods against the standard 12-lead ECG during percutaneous coronary intervention (PCI)...
  55. doi request reprint The touch that heals: the uses and meanings of touch in the clinical encounter
    Drew Leder
    Department of Philosophy, Loyola College in Maryland, Baltimore, MD 21210, USA
    J Altern Complement Med 14:321-7. 2008
    ..This paper explores the unique properties of touch as a medium of perception, action, and expression that can render touch a healing force within the clinical encounter...
  56. ncbi request reprint Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and In
    John H K Vogel
    J Am Coll Cardiol 46:184-221. 2005
  57. ncbi request reprint Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction
    Paul Sorajja
    Mayo Clinic, Rochester, MN, USA
    Am Heart J 154:379-84. 2007
    ..We sought to examine the impact of baseline collateral flow to the IRA on reperfusion success, infarct size, and clinical outcomes in patients undergoing primary PCI for acute myocardial infarction (AMI)...
  58. ncbi request reprint Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention
    William W O'Neill
    Leonard M Miller School of Medicine, University of Miami, P O Box 016099 R 699, Miami, Florida 33101, USA
    J Am Coll Cardiol 50:397-405. 2007
    ..This study sought to determine whether hyperoxemic reperfusion with aqueous oxygen (AO) improves recovery of ventricular function after percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...